Influence of patient-centered HIV care on retention and viral suppression disparities
以患者为中心的艾滋病毒护理对保留和病毒抑制差异的影响
基本信息
- 批准号:10524757
- 负责人:
- 金额:$ 29.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-29 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdministratorAdultAffectAfrican American populationAmericanAntiviral AgentsAttitudeBayesian NetworkBuffersCaringCase ManagementCharacteristicsClientClinicalClinical assessmentsCohort StudiesCommunicationCommunitiesCommunity SurveysCountyDataDisparityEconomically Deprived PopulationEnrollmentEnsureFocus GroupsFundingHIVHIV InfectionsHealthcare SystemsHousingHumanImmunologic Deficiency SyndromesIncidenceIndividualInfluentialsInterventionInterviewKnowledgeLaboratoriesLatino PopulationMedicalMinority GroupsNeighborhoodsOutcomePatient PreferencesPatient-Centered CarePatientsPersonsPharmaceutical PreparationsPovertyProspective, cohort studyProviderPsychosocial FactorReduce health disparitiesResearchRoleSelf ManagementServicesSiteSurveysSystemTestingTreatment outcomeUnited StatesUnited States National Institutes of HealthViralVirusacceptability and feasibilityantiretroviral therapybilling datacare outcomescultural competencedisparity reductiondynamic systemeffective interventionepidemic virusethnic disparityethnic minorityhealth disparityhealth literacyimprovedindividual patientinnovationlow health literacymedical specialtiesmedically underservedmortalitypatient orientedpreventprogramsprovider factorspsychosocialracial disparityracial minorityresistant strainretention rateskillssocial determinantssocial stigmasocioeconomic disadvantagetherapy adherencetherapy developmenttransmission processtreatment disparity
项目摘要
PROJECT SUMMARY
Achieving high rates of retention in human immunodeficiency (HIV) care and viral suppression through
antiretroviral therapy not only reduces mortality, but also is a means to reduce the incidence of HIV in affected
communities because viral suppression greatly decreases communicability and prevents the transmission of
resistant strains of the virus. Retention in care and viral suppression have been particularly challenging for
minority populations leading to racial and ethnic disparities in HIV outcomes, including survival. Among people
living with HIV infection in 2013, the percentage that was virally suppressed was only 51.5% among African
Americans, 58.2% among Latinos, and 65.0% among whites. Our central hypothesis is that provider patient-
centered care (PCC) factors interacting with dynamic patient psychosocial factors as well as neighborhood
social determinants and medical case management site factors are influencing retention in care and viral
suppression and thus contributing to health disparities. The objective of this application is to identify provider
PCC factors that are moderating the effect of changes in individual characteristics on retention in care and viral
suppression while considering neighborhood social determinants and medical case management site factors
and to predict to what extent changes in PCC factors could improve HIV care retention and viral suppression
and thus reduce health disparities. We will accomplish these objectives with a cohort study of people enrolled
in the Miami-Dade County Ryan White Program 2019–2021. The Ryan White Program serves 52% of people
living with HIV in the United States, in particular the medically underserved. To test our central hypothesis and
achieve the objectives of this application, we propose the following four specific aims: 1) Using causal
Bayesian networks, assess the moderating role of HIV provider PCC factors on the association between
patient-level characteristics and retention in HIV care, viral suppression, and related health disparities cross-
sectionally while accounting for neighborhood-level and medical case management site factors; 2) By means
of dynamic causal Bayesian networks, assess the moderating role of HIV provider PCC factors on the
association between longitudinal changes in patient-level characteristics and changes in retention in HIV care,
viral suppression, and related health disparities; 3) Using dynamic causal Bayesian networks, estimate the
magnitude of the expected improvement in retention in HIV care, viral suppression, and related health
disparities, produced by changing provider PCC factors; and 4) Identify feasibility and acceptability issues
related to potential interventions to address the most influential health disparities factors identified in aims 1–3
using expert interviews and focus group discussions with RWP providers, administrators, and patients. This
research thus supports one of the Trans-NIH Plan for HIV-Related Research “cross-cutting” priorities to reduce
disparities in treatment outcomes.
项目摘要
通过以下措施实现高的艾滋病毒护理和病毒抑制保留率
抗逆转录病毒治疗不仅降低死亡率,而且是降低受影响人群中艾滋病毒发病率的一种手段。
社区,因为病毒抑制大大降低了传播性,并防止传播
抵抗病毒的菌株。保持护理和病毒抑制对于
少数群体的艾滋病毒感染导致艾滋病毒结果的种族和族裔差异,包括生存率。人与人之间
2013年,非洲艾滋病毒感染者中,病毒抑制率仅为51.5%,
美国人中,58.2%是拉丁裔,65.0%是白人。我们的核心假设是提供者-
中心化护理(PCC)因素与动态患者心理社会因素以及邻居相互作用
社会决定因素和医疗病例管理地点因素正在影响护理保留率,
抑制,从而造成健康差距。此应用程序的目的是确定提供商
PCC因素是调节个体特征变化对保持护理和病毒感染的影响。
抑制,同时考虑邻里社会因素和医疗病例管理现场因素
并预测PCC因素的变化在多大程度上可以改善HIV护理保留和病毒抑制
从而减少健康差距。我们将通过对招募人员进行队列研究来实现这些目标
迈阿密戴德县瑞安白色计划2019 - 2021。瑞安白色计划为52%的人提供服务
艾滋病毒感染者在美国,特别是医疗服务不足。为了验证我们的核心假设,
为了实现本申请的目的,我们提出了以下四个具体目标:1)使用因果关系
贝叶斯网络,评估艾滋病毒提供者PCC因素对之间关联的调节作用
患者水平的特征和艾滋病毒护理的保留,病毒抑制和相关的健康差异,
分区,同时考虑社区水平和医疗病例管理现场因素; 2)通过手段
动态因果贝叶斯网络,评估艾滋病毒提供者PCC因素对艾滋病毒感染的调节作用。
患者水平特征的纵向变化与艾滋病毒护理保留率的变化之间的关联,
病毒抑制和相关的健康差异; 3)使用动态因果贝叶斯网络,估计
在艾滋病毒护理、病毒抑制和相关健康方面预期改善的幅度
差异,由不断变化的供应商PCC因素产生;以及4)确定可行性和可接受性问题
与解决目标1 - 3中确定的最具影响力的健康差距因素的潜在干预措施有关
使用专家访谈和与RWP提供者、管理者和患者的焦点小组讨论。这
因此,研究支持跨NIH计划的艾滋病毒相关研究“交叉”优先事项之一,以减少
治疗结果的差异。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY JO TREPKA其他文献
MARY JO TREPKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY JO TREPKA', 18)}}的其他基金
Influence of patient-centered HIV care on retention and viral suppression disparities
以患者为中心的艾滋病毒护理对保留和病毒抑制差异的影响
- 批准号:
10447915 - 财政年份:2019
- 资助金额:
$ 29.58万 - 项目类别:
Influence of patient-centered HIV care on retention and viral suppression disparities
以患者为中心的艾滋病毒护理对保留和病毒抑制差异的影响
- 批准号:
10307102 - 财政年份:2019
- 资助金额:
$ 29.58万 - 项目类别:
Influence of patient-centered HIV care on retention and viral suppression disparities
以患者为中心的艾滋病毒护理对保留和病毒抑制差异的影响
- 批准号:
10058773 - 财政年份:2019
- 资助金额:
$ 29.58万 - 项目类别:
Women-centered HIV care practices that facilitate HIV care retention and viral suppression in the presence of adverse sociocultural factors
以妇女为中心的艾滋病毒护理实践,有助于在存在不利社会文化因素的情况下保留艾滋病毒护理和抑制病毒
- 批准号:
10366257 - 财政年份:2018
- 资助金额:
$ 29.58万 - 项目类别:
Women-centered HIV care practices that facilitate HIV care retention and viral suppression in the presence of adverse sociocultural factors
以妇女为中心的艾滋病毒护理实践,有助于在存在不利社会文化因素的情况下保留艾滋病毒护理和抑制病毒
- 批准号:
9925657 - 财政年份:2018
- 资助金额:
$ 29.58万 - 项目类别:
Women-centered HIV care practices that facilitate HIV care retention and viral suppression in the presence of adverse sociocultural factors
以妇女为中心的艾滋病毒护理实践,有助于在存在不利社会文化因素的情况下保留艾滋病毒护理和抑制病毒
- 批准号:
10038590 - 财政年份:2018
- 资助金额:
$ 29.58万 - 项目类别:
Women-centered HIV care practices that facilitate HIV care retention and viral suppression in the presence of adverse sociocultural factors
以妇女为中心的艾滋病毒护理实践,有助于在存在不利社会文化因素的情况下保留艾滋病毒护理和抑制病毒
- 批准号:
9658129 - 财政年份:2018
- 资助金额:
$ 29.58万 - 项目类别:
Women-centered HIV care practices that facilitate HIV care retention and viral suppression in the presence of adverse sociocultural factors
以妇女为中心的艾滋病毒护理实践,有助于在存在不利社会文化因素的情况下保留艾滋病毒护理和抑制病毒
- 批准号:
10381616 - 财政年份:2018
- 资助金额:
$ 29.58万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant














{{item.name}}会员




